Related Experiment Video
Updated: Mar 14, 2026

Primary Culture of Mouse Dopaminergic Neurons
Published on: September 8, 2014
Cell-autonomous and non-cell-autonomous drivers of dopamine neuron vulnerability in Parkinson's disease
Alex Tchung1, Amandine Even2, Louis-Éric Trudeau3
1Department of Pharmacology and Physiology, Faculty of Medicine, Université de Montréal, Montreal, Quebec, Canada; Neural Signaling and Circuitry Research Group (SNC), Montreal, Quebec, Canada; Center for Interdisciplinary Research on the Brain and Learning (CIRCA), Montreal, Quebec, Canada; Courtois Institute for Biomedical Innovation (CI(2)B), Montreal, Quebec, Canada.
Abstract:
The motor symptoms of Parkinson's disease are linked to age-dependent degeneration of dopamine neurons. Traditionally, the loss of these neurons has been thought to stem mainly from cell-autonomous cellular dysfunctions. However, there is growing evidence suggesting that it could result from complex interactions between cell-autonomous and non-cell-autonomous mechanisms. This review article examines evidence for cell-autonomous mechanisms linked to mitochondrial, lysosomal, or proteasomal perturbations and for non-cell-autonomous processes arising from glial and peripheral immune cells. We discuss how these pathways can converge to create chronic cellular stress and trigger cell death mechanisms. Beyond highlighting apoptosis as a key mode of degeneration, we consider the contribution of other mechanisms, including pyroptosis and ferroptosis. Understanding the relative dominance of these mechanisms across disease stages and patient subgroups could help guide the development of mechanism-based neuroprotective strategies.
More Related Videos
14:45Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
Published on: July 29, 2022
09:21Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
Published on: July 7, 2023
Related Concept Videos
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Neural Regulation
Drugs Affecting Neurotransmitter Synthesis
EPS and iPS Cells in Disease Research